Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Coltuximab Biosimilar – Anti-CD19 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Coltuximab Biosimilar - Anti-CD19 mAb - Research Grade |
|---|---|
| Source | CAS 1269764-99-9 |
| Species | Chimeric |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Coltuximab,SAR3419,CD19 ,anti-CD19 |
| Reference | PX-TA1345 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1, kappa |
| Clonality | Monoclonal Antibody |
Description of Coltuximab Biosimilar - Anti-CD19 mAb - Research Grade
General information on Anti-CD19 [Homo sapiens] (Coltuximab) Monoclonal Antibody
Coltuximab ravtansine is directed against CD19 and is investigated to treat acute lymphoblastic leukemia.
SDS-PAGE for Coltuximab Biosimilar - Anti-CD19 mAb
Coltuximab Biosimilar - Anti-CD19 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Contact us
Send us a message from the form below
Reviews
There are no reviews yet.